N@N

PHILADELPHIA--([ BUSINESS WIRE ])--Chemtura Corporation (NYSE: CHMT) today announced that the French Autorit des marchs financiers (AMF) has approved the Companyas prospectus for admission of its common stock to listing and trading on the Professional Segment of NYSE Euronext in Paris (aEuronexta), and has granted visa number 12-225, dated May 25, 2012, on the prospectus (the aProspectusa). The Prospectus has been prepared by Chemtura Corporation and its signatory accepts the responsibility for its contents. The attention of investors is drawn to the risk factors described in the Prospectus. On May 24, 2012, Euronext approved Chemtura Corporationas application for listing and trading of its common stock on Euronext.

Chemtura Corporationas common stock is scheduled to begin trading on Euronext on June 1, 2012. The Companyas common stock will trade under the symbol aCHMTa and be denominated in Euros on the Euronext exchange. This listing will not alter Chemtura Corporationas share count, capital structure, or current stock listing on the New York Stock Exchange, where it also trades under the symbol aCHMT.a

The Company believes this cross listing will provide European investors a greater opportunity to access Chemtura Corporationas shares in the future. As an NYSE listed company, Chemtura Corporation obtained its cross listing on the NYSE Euronext in Paris through the Fast Path program.

Copies of the Prospectus may be obtained free of charge from Chemtura Corporation at 1818 Market Street, Suite 3700, Philadelphia, Pennsylvania 19103, U.S.A., from its paying agent, Socit Gnrale (Postal address: 32, rue du Champ de Tir, BP 81236, 44312 Nantes Cedex 3, France), and on the websites of Chemtura Corporation ([ www.chemtura.com ]) and the AMF ([ www.amf-france.org ]).

Chemtura Corporation, with 2011 sales of $3 billion, is a global manufacturer and marketer of specialty chemicals, agrochemicals and pool, spa and home care products. Additional information concerning Chemtura is available at [ www.chemtura.com ].